Scientists deploy Merck’s Ebola vaccine in DRC

The Ebola outbreak in the Democratic Republic of the Congo is expanding at an unprecedented rate, prompting scientists to take unprecedented steps to contain it. One such step is the deployment of Merck's Ervebo vaccine, which protects against a different species of Ebola virus. The vaccine's use is being explored as a potential tool to help curb the outbreak.